Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Treatment of Winlevi With Duac Gel in Patients With Acne Vulgaris

NCT06336629 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries Limited as lead sponsor.

NCT NCT06336629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06336629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Treatment of Winlevi With Duac Gel in Patients With Acne Vulgaris
Lead sponsor
Sun Pharmaceutical Industries Limited
Phase
Phase 4
Overall status
Completed
Start date
November 15, 2023
Completion date
July 10, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris